We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Inflammatory Markers in Preeclampsia

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01385813
First Posted: June 30, 2011
Last Update Posted: July 18, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Oslo University Hospital
  Purpose
This is an investigation of inflammatory markers in women destined to develop preeclampsia.

Condition
Preeclampsia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by Oslo University Hospital:

Enrollment: 129
Study Start Date: January 1999
Study Completion Date: May 2004
Primary Completion Date: May 2004 (Final data collection date for primary outcome measure)
Groups/Cohorts
Pregnant women who develop preeclampsia
pregnant women who develop preeclampsia (n =43) compared to pregnant women fulfilling a normotensive pregnancy (n= 86).

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 43 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

The study comprised 43 pregnant women who developed preeclampsia and 86 pregnant women who fulfilled a normotensive pregnancy.

All women were of Caucasian origin, and were nulliparous.

Criteria

Inclusion Criteria:

  • Caucasian origin

Exclusion Criteria:

  • Previous diseases e.g. cardiovascular disease, diabetes, hypertension, inflammatory bowel disease, serious organ disease
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Professor Lars Mørkrid, University of Oslo
ClinicalTrials.gov Identifier: NCT01385813     History of Changes
Other Study ID Numbers: INFLAMMARPE11
First Submitted: June 29, 2011
First Posted: June 30, 2011
Last Update Posted: July 18, 2011
Last Verified: May 2011

Keywords provided by Oslo University Hospital:
pre-eclampsia
inflammatory markers
serological biobank
To assess whether the inflammatory markers could be useful
in order to identify pregnant women at risk to
develop preeclampsia

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications